サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1637687

アジア太平洋の放射線腫瘍学市場：2031年までの予測 - 地域別分析 - タイプ別、用途別

Asia Pacific Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application

出版日
ページ情報
英文 89 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
アジア太平洋の放射線腫瘍学市場：2031年までの予測 - 地域別分析 - タイプ別、用途別
出版日: 2024年11月22日
発行: The Insight Partners
ページ情報: 英文 89 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の放射線腫瘍学市場は、2023年に11億574万米ドルとなり、2031年までには34億1,789万米ドルに達すると予測され、2023年から2031年までのCAGRは15.1%を記録すると予測されています。

放射線腫瘍学の戦略的取り組みがアジア太平洋の放射線腫瘍学市場を後押し

放射線腫瘍学は、がん治療において大きな可能性を秘めています。また、製品開発、技術革新、製品発売、製品承認、合併、買収、提携など、市場プレーヤーによる放射線治療の絶え間ない進化が市場成長に寄与すると期待されています。同市場で最近行われた戦略的イニシアチブの一部を紹介します。

  • 2024年5月、Elektaは、最新の線形加速器（リニアック）であるEvoを発売しました。Evoは、新しい高精細AI強化イメージングを搭載したCT-リニアックで、標準的な画像誘導放射線治療だけでなく、オフラインおよびオンライン適応放射線治療を改善することができます。
  • 2024年5月、Icon GroupはCyberknife Australia Pty Ltdと提携し、「サイバーナイフ」システムを使用した放射線腫瘍治療を提供する最大6つの放射線腫瘍クリニックを新設（合弁事業案）しました。
  • 2024年5月、GE HealthCareは、革新的なハードウェアおよびソフトウェアソリューションを搭載した新しい放射線治療用CTソリューションであるレボリューションRTを発売しました。
  • 2024年4月、Accuray IncorporatedはESTRO 2024において、がん治療体験を向上させるために設計されたハードウェアとソフトウェアの進歩を展示しました。最新世代のサイバーナイフとRadixactプラットフォームは、放射線治療の治癒力を拡大し、今年の会議の焦点であるケアギャップを埋めるために必要な技術を医療チームに提供します。
  • 2023年9月、MVision AIは、効果的な放射線治療の輪郭形成のための初の包括的なGuideline-Based Segmentation（GBS）ソリューションを発表しました。Guideは、臨床チームがAIが生成した構造を正確に評価することを容易にし、輪郭形成のスキルを向上させることを可能にします。Verifyは、輪郭の視覚的・体積的比較を可能にし、クリニックが類似点や相違点を観察することを容易にします。Guide VerifyとContour+を組み合わせて導入することで、放射線治療の輪郭形成におけるあらゆる臨床ニーズが網羅されます。

したがって、放射線腫瘍学市場で事業を展開する市場プレイヤーの間で戦略的イニシアティブが急増しており、これが市場の成長を加速させ、放射線腫瘍学市場に十分な機会を創出すると期待されています。

アジア太平洋の放射線腫瘍学市場の概要

放射線腫瘍学の分野は、著しい技術進歩により中国で急速に開発されています。放射線腫瘍学システムへのアクセスを高める上で、合弁事業が重要な役割を果たしています。こうした取り組みにより、企業はハイテク治療製品の開発にも力を入れています。China Isotope and Radiation Corporation（CIRC）と米国の放射線治療システム開発企業であるAccurayは、2019年1月に合弁会社を設立しました。このプロジェクトでは、Accurayの最先端治療ソリューションと現地製造能力を活用し、中国市場のアンメットニーズに対応します。このようなイニシアチブは、中国国内における放射線腫瘍学スキルの開拓に対する中国の献身を示すものであり、今後数年間、放射線腫瘍学市場に注目すべき展望を生み出すと思われます。

アジア太平洋の放射線腫瘍学市場の収益と2031年までの予測（金額）

アジア太平洋の放射線腫瘍学市場のセグメンテーション

アジア太平洋の放射線腫瘍学市場は、タイプ、用途、および国に分類されます。

タイプ別に見ると、アジア太平洋の放射線腫瘍学市場は外照射療法と内照射療法に二分されます。2023年の市場シェアは、外照射療法分野が大きくなりました。

用途別では、アジア太平洋の放射線腫瘍学市場は乳がん、前立腺がん、肺がん、頭頸部がん、子宮頸がん、その他に分類されます。2023年には乳がん分野が最大の市場シェアを占めました。

国別では、アジア太平洋の放射線腫瘍学市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。2023年のアジア太平洋の放射線腫瘍学市場シェアは中国が独占しました。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide（Ion Beam Applications SA）、Becton Dickinson and Co、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc、Panacea Medical Technologies Pvt.Ltd、およびCuriumは、アジア太平洋の放射線腫瘍学市場で事業を展開している主要企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 アジア太平洋の放射線腫瘍学市場：主要市場力学

  • 市場促進要因
    • がんの有病率の増加
    • 放射線腫瘍学の開発を支援する取り組み
  • 市場抑制要因
    • 放射線治療機器の高コスト
  • 市場機会
    • 放射線腫瘍学における戦略的イニシアティブ
  • 今後の動向
    • 放射線腫瘍学の技術進歩
  • 促進要因と抑制要因の影響

第5章 放射線腫瘍学市場：アジア太平洋市場分析

  • 放射線腫瘍学市場の収益、2021年～2031年

第6章 アジア太平洋の放射線腫瘍学市場分析：タイプ別

  • 外部ビーム放射線療法
  • 内部ビーム放射線療法

第7章 アジア太平洋の放射線腫瘍学市場分析：用途別

  • 乳がん
  • 前立腺がん
  • 肺がん
  • 頭頸部がん
  • 子宮頸がん
  • その他

第8章 アジア太平洋の放射線腫瘍学市場：国別分析

  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • アジア太平洋のその他諸国

第9章 放射線腫瘍学市場：業界情勢

  • 放射線腫瘍学市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第10章 企業プロファイル

  • Varian Medical Systems Inc
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide（Ion Beam Applications SA）
  • Becton Dickinson and Co
  • Mevion Medical Systems
  • NTP RADIOISOTOPES
  • Mallinckrodt Plc
  • Panacea Medical Technologies Pvt. Ltd
  • Curium

第11章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Radiation Oncology Market Segmentation
  • Table 2. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 3. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 4. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 5. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 7. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 8. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 9. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 11. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 12. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 13. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 15. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 16. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 17. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 19. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 20. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 21. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 22. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 24. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 25. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
  • Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
  • Table 28. Glossary of Terms, Radiation Oncology Market

List Of Figures

  • Figure 1. Asia Pacific Radiation Oncology Market Segmentation, by Country
  • Figure 2. Radiation Oncology Market - Key Market Dynamics
  • Figure 3. Statistics at Glance, Global, 2022
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
  • Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
  • Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Asia Pacific Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 17. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 19. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Growth Strategies in Radiation Oncology Market
目次
Product Code: BMIRE00030984

The Asia Pacific radiation oncology market was valued at US$ 1,105.74 million in 2023 and is expected to reach US$ 3,417.89 million by 2031; it is estimated to record a CAGR of 15.1% from 2023 to 2031.

Strategic Initiatives in Radiation Oncology Boost Asia Pacific Radiation Oncology Market

Radiation Oncology holds tremendous potential in cancer treatment. Additionally, constant evolution in radiotherapy by the market players in terms of product development, innovation, product launch, product approval, merger, acquisition and partnerships, and others is expected to contribute the market growth. Some of the recent strategic initiatives taken place in the market are

  • In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.
  • In May 2024, The Icon Group collaborated with Cyberknife Australia Pty Ltd to establish up to 6 new radiation oncology clinics (proposed joint venture), which will provide radiation oncology treatments using the 'Cyberknife' system.
  • In May 2024, GE HealthCare launched Revolution RT, a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.
  • In April 2024, Accuray Incorporated showcased advancement in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife and Radixact platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy and delivering on the focus of this year's congress, bridging the care gap.
  • In September 2023, MVision AI launched the first comprehensive Guideline-Based Segmentation (GBS) solution for effective radiation therapy contouring. Guide facilitates clinical teams to accurately evaluate AI-generated structures, thus enabling them to refine their contouring skills. Verify allows visual and volumetric comparison of contours, facilitating clinics to observe similarities and differences. The combined implementation of Guide Verify and Contour+ encompasses all clinical needs in radiotherapy contouring.

Therefore, surging strategic initiatives among market players operating in radiation oncology market which are expected to amplify the market growth and create ample opportunities for the radiation oncology market.

Asia Pacific Radiation Oncology Market Overview

The field of radiation oncology has been developing quickly in China due to significant technological advancements. Joint ventures have played a crucial role in increasing the accessibility of radiation oncology systems. With these initiatives, companies also focus on developing high-tech therapy products. China Isotope and Radiation Corporation (CIRC) and Accuray, a US-based developer of radiotherapy systems, established a joint venture in January 2019. This project uses Accuray's cutting-edge treatment solutions and local manufacturing capabilities to address the unmet needs in the Chinese market. Such initiatives demonstrate China's dedication to developing radiation oncology skills within the country, which would generate noteworthy prospects for the radiation oncology market in the coming years.

Asia Pacific Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Radiation Oncology Market Segmentation

The Asia Pacific radiation oncology market is categorized into types, application, and country.

Based on types, the Asia Pacific radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the Asia Pacific radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the Asia Pacific radiation oncology market is segmented into the China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Panacea Medical Technologies Pvt. Ltd,, and Curium are some of the leading companies operating in the Asia Pacific radiation oncology market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Radiation Oncology Market - Key Market Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Increasing Prevalence of Cancer
    • 4.1.2 Initiatives to Support Developments in Radiation Oncology
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Radiotherapy Equipment
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives in Radiation Oncology
  • 4.4 Future Trends
    • 4.4.1 Technological Advancement in Radiation Oncology
  • 4.5 Impact of Drivers and Restraints:

5. Radiation Oncology Market - Asia Pacific Market Analysis

  • 5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

6. Asia Pacific Radiation Oncology Market Analysis - by Types

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Overview
    • 6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Internal Beam Radiation Therapy
    • 6.2.1 Overview
    • 6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Radiation Oncology Market Analysis - by Application

  • 7.1 Breast Cancer
    • 7.1.1 Overview
    • 7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Prostate Cancer
    • 7.2.1 Overview
    • 7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Lung Cancer
    • 7.3.1 Overview
    • 7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Head and Neck Cancer
    • 7.4.1 Overview
    • 7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Cervical Cancer
    • 7.5.1 Overview
    • 7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Radiation Oncology Market - Country Analysis

  • 8.1 Asia Pacific
    • 8.1.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 8.1.1.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.1.1 China: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.1.4 China: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.2.1 Japan: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.2.4 Japan: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.3.1 India: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.3.4 India: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.4.1 Australia: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.4.4 Australia: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
      • 8.1.1.6 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.6.1 Rest of APAC: Radiation Oncology Market Breakdown, by Types
        • 8.1.1.6.2 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 8.1.1.6.3 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 8.1.1.6.4 Rest of APAC: Radiation Oncology Market Breakdown, by Application

9. Radiation Oncology Market - Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in Radiation Oncology Market
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Inorganic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Varian Medical Systems Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview (Siemens Healthineers AG)
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Elekta AB
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Accuray Incorporated
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 IBA Worldwide (Ion Beam Applications SA)
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Becton Dickinson and Co
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Mevion Medical Systems
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 NTP RADIOISOTOPES
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Mallinckrodt Plc
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Panacea Medical Technologies Pvt. Ltd
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Curium
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms